Skip to content

PHARMAPOINT

Active Public limited companyfounded 1988active for 38 yearsThomasboslaan 98, 3630 MaasmechelenKBO/BCE: BE 0435.330.555 subsidiary of MEDIPHARMA

Mandates through the years

2 names, the dashed line is today
Antoon Medaer
Managing director
BV Medipharma
Managing director
Earliermandate already running before its first mentionend not dated
Mandates as a list
  • Antoon Medaer
    • Director, appointed by deed of 09-08-2021, until 13-07-2023
    • Managing director, from before 05-07-2023, ended, last mentioned on 13-07-2023
  • BV Medipharma
    • Director, from before 29-05-2021 to 13-07-2023
    • Managing director, from before 29-05-2021 to 13-07-2023

Control

Parent
Equity €2.0m
Profit €94,281 in 2025 (profit €149,317 in 2024)
100%
This company
PHARMAPOINT
Equity €106,312
Profit €85,567 in 2025

Capital

Capital
€62,000
Shares
125
Contribution per share
€496
Equity per share
€850 in 2025
Source
deed of 13-07-2023

Owners through the years

as the annual accounts name them
Owners as a list

Source: lists of holdings in the owners' accounts

Articles of association

deed of 13-07-2023 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 3 directors
“Behoudens andersluidende beslissing algemene vergadering, algemene vergadering kan zitpenningen toekennen”
“Algemene vergadering kan mandaat te allen tijde zonder opgave van redenen met onmiddellijke ingang beëindigen”
“Onmiddellijk tweede stembeurt, elke bestuurder kan aan één collega volmacht verlenen voor bepaalde raad en stemming”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of May at 20:00
Dissolution ruleThe articles set when and by whom the company can be dissolved.
“Besluit van de algemene vergadering, zoals inzake statutenwijziging”

Office holders in the KBO →

Next steps